Two Philadelphia biotech companies scored approval in 2024 for first-of-their-kind gene therapy treatments for solid cancer ...

Two former internet messageboard darlings that fell from grace a few years ago have been the year's biggest winners on the ...

Morgans analyst Iain Wilkie said 2024 was "pretty patchy" for the ASX healthcare sector, which underperformed broader markets ...